Following the recommendations of the authorities for the coronavirus pandemic, SARA Pharm has taken the necessary measures to ensure the continuity of its activity. The current projects are on-going. The laboratory is operational and the necessary precautions have been taken to allow the safe reception of samples. We do not foresee any impact on our activity to date. In the event of an evolution, we will not fail to keep you informed.

August 15th, 2011

SARA Pharm Solutions announces the purchase of a new D8 DISCOVER DAVINCI ( instrument. This High Throughput X-Ray Powder Diffraction (HT-XRPD) instrument is ready to run a 96-well plate in only 2.5hrs.